Transfusion

Estimating blood donor loss due to the variant CJD travel deferral.

Transfusion

Murphy EL, David Connor J, McEvoy P, Hirschler N, Busch MP, Roberts P, Nguyen KA, Reich P

Clinical significance of nondiscriminated reactive results with the Chiron Procleix HIV-1 and HCV assay.

Transfusion

McAuley JD, Caglioti S, Williams RC, Robertson GF, Morgan L, Tobler LH, Busch MP

Behavioral and infectious disease risks in young blood donors: implications for recruitment.

Transfusion

Damesyn MA, Glynn SA, Schreiber GB, Ownby HE, Bethel J, Fridey J, McMullen Q, Garratty G, Busch MP

Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screening.

Transfusion

Tobler LH, Stramer SL, Lee SR, Masecar BL, Peterson JE, Davis EA, Andrews WE, Brodsky JP, Kleinman SH, Phelps BH, Busch MP

HCV viral load in anti-HCV-reactive donors and infectivity for their recipients.

Transfusion

Operskalski EA, Mosley JW, Tobler LH, Fiebig EW, Nowicki MJ, Mimms LT, Gallarda J, Phelps BH, Busch MP

Absence of activation of CMV by blood transfusion to HIV-infected, CMV-seropositive patients.

Transfusion

Drew WL, Chou S, Mohr BA, Assmann SF, Miner RC, Laycock ME, Busch MP

Very low level viremia in HCV infectious unit missed by NAT.

Transfusion

Busch MP, Tobler LH, Gerlich WH, Schaefer S, Giachetti C, Smith R

Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection.

Transfusion

Biswas R, Tabor E, Hsia CC, Wright DJ, Laycock ME, Fiebig EW, Peddada L, Smith R, Schreiber GB, Epstein JS, Nemo GJ, Busch MP

Pages